Tranexamic acid, CAS 1197-18-8

Tranexamic acid, CAS 1197-18-8
Artikelnummer
MEXHY-B0149-10.1
Verpackungseinheit
10 mM/1 ml
Hersteller
MedChemExpress

Verfügbarkeit: wird geladen...
Preis wird geladen...
Product Description: Tranexamic acid (cyclocapron), a cyclic analog of lysine, is an orally active antifibrinolytic agent. Tranexamic acid attenuates the effects of severe trauma, inhibits urokinase plasminogen activator and ameliorates dry wrinkles. Tranexamic acid can used for the research of hemostasis [1][2][3][4][5].

Applications: COVID-19-immunoregulation

Formula: C8H15NO2

References: [1]Prudovsky I, et al. Tranexamic acid suppresses the release of mitochondrial DNA, protects the endothelial monolayer and enhances oxidative phosphorylation [J]. Journal of cellular physiology, 2019, 234(11): 19121-19129./[2]Wu G, et al. Tranexamic acid is an active site inhibitor of urokinase plasminogen activator [J]. Blood advances, 2019, 3(5): 729-733./[3]Draxler D F, et al. Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis [J]. Journal of Thrombosis and Haemostasis, 2019, 17(12): 2174-2187./[4]Hiramoto K, et al. The amelioration effect of tranexamic acid in wrinkles induced by skin dryness [J]. Biomedicine & Pharmacotherapy, 2016, 80: 16-22./[5]Sindet-Pedersen S, et al. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery [J]. New England Journal of Medicine, 1989, 320(13): 840-843.

CAS Number: 1197-18-8

Molecular Weight: 157.21

Compound Purity: 98.0

Research Area: Cancer; Neurological Disease; Cardiovascular Disease

Solubility: DMSO : < 1 mg/mL/H2O : 50 mg/mL (ultrasonic)

Target: AMPK;IGF-1R;Mitophagy;MMP
Mehr Informationen
Artikelnummer MEXHY-B0149-10.1
Hersteller MedChemExpress
Hersteller Artikelnummer HY-B0149-10.1
Verpackungseinheit 10 mM/1 ml
Mengeneinheit STK
Produktinformation (PDF) Download
MSDS (PDF) Download